Idera Pharma (IDRA) Files $75M Mixed Shelf
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) filed a registration with the U.S. SEC to sell, from time to time, up to $75 million of Common Stock, Preferred Stock, Depositary Shares, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Nanosphere (NSPH) Commences Common Stock Offering, Prelim. Q3 Revs Top Expectations
- General Steel Holdings (GSI) Provides Update on Private Placement
- WidePoint (WYY) Falls on Stock Offering
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!